Scientists have developed a revolutionary laser treatment to prevent blindness. This non-invasive therapy uses ultra-short ...
Coave Therapeutics unveils lead gene therapy program for retinal vascular diseases, powered by first-in-class vector for ...
Macular degeneration, particularly age-related macular degeneration, is a leading cause of vision loss worldwide. This condition affects the central part of the retina, known as the macula, which is ...
HAYWARD, Calif., Feb. 28, 2025 /PRNewswire/ -- Avirmax Biopharma, Inc., a leader in developing the next generation of AAV gene therapies, today announced the commencement of Investigational New Drug ...
Retinal diseases such as age-related macular degeneration (AMD) and diabetic retinopathy affect millions of people globally, often leading to vision loss with minimal straightforward treatment.
Toll-like receptors, or TLRs, are the immune system’s early warning sensors. They detect microbial invaders and damage signals, helping the body mount a defense. But when TLR signaling veers off ...
Our task now is to translate that advantage into stopping more people from becoming blind by offering a product that is easier to use and works better.” — Filamon CEO, Dr Graham Kelly SYDNEY, NSW, ...
APOLLO BEACH, Fla., Feb. 20, 2025 (GLOBE NEWSWIRE) -- RetinalGenix Technologies Inc OTCQB:RTGN (“RetinalGenix” or the “Company”), announced today that it has achieved an important milestone in ...